Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.4103/0971-5851.103148
Uterine smooth muscle tumor of uncertain malignant potential: A rare cause of multiple pulmonary nodules
![](https://www.thieme-connect.de/media/10.1055-s-00050348/201203/lookinside/thumbnails/10_4103_0971-5851_103148_176-1.jpg)
Abstract
Smooth muscle tumors of uncertain malignant potential (STUMP) are mesenchymal uterine tumors lying between benign leiomyomas and leiomyosarcomas. Although lung metastases from uterine leiomyosarcoma are common, ′′STUMP′′ usually does not metastasize. A case of a 51-year-old woman with progressive dyspnea on exertion and multiple space-occupying lesions in both lungs is presented. She had a history of a total abdominal hysterectomy 3 years ago. Lung biopsy through video-assisted thoracic surgery was consistent with metastatic malignant smooth muscle cell tumor. She received multiple cycles of chemotherapy and died 11 months later. Cell necrosis, atypia and mitotic count are important criteria determining the malignant potential of a uterine smooth muscle tumor. The diagnosis and clinical course of STUMP are not totally and clearly known, and metastasis, especially pulmonary with pleural effusion, is not a common phenomenon. When this occurs, prognosis seems to be poor. Surveillance of these patients should be close and long term.
Publication History
Article published online:
02 August 2021
© 2012. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Ip PP, Cheung AN, Clement PB. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases. Am J Surg Pathol 2009;33:992-1005.
- 2 Unver NU, Acikalin MF, Oner U, Ciftci E, Ozalp SS, Colak E. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors. Arch Gynecol Obstet 2011;284:483-90.
- 3 Ng JS, Han A, Chew SH, Low J. A clinicopathologic study of uterine smooth muscle tumours of uncertain malignant potential (STUMP). Ann Acad Med Singapore 2010;39:625-8.
- 4 Kong CS, Longacre TA, Hendrickson MR. Pathology. In: Berek JS, Hacker NF, Editors. Gynecologic Oncology. 5 th Ed. Section I, chapter 5, Philadelphia: Lippincott Williams and Wilkins; 2010. p. 166-70.
- 5 Hacker NF, Friedlander M. Uterine Cancer. In: Berek JS, Hacker NF, Editors. Gynecologic Oncology. 5 th Ed. Section II, chapter 10, Philadelphia: Lippincott Williams and Wilkins. 2010. p. 430-2.
- 6 Schorge J, Schaffer J, Halvorson L, Hoffman B, Brandshaw K, Cunningham FG. Williams Gynecology. Edition I, New York City, U.S: McGraw-Hill; 2008;34:708.
- 7 Nagata J, Nishi H, Nakamura A, Fukuo S, Kosaka J. A case of uterine myxoid leiomyosarcoma with positive cytology in pleural effusion. Nippon Sanka Fujinka Gakkai Zasshi 1996;48:293-5.